<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">To achieve the Ebola vaccinesâ€™ 5-year clinical program, global regulators from developed countries combined and leveraged their collective expertise to assist the African Vaccine Regulatory Forum and worked closely with vaccine developer Merck to conduct supporting and pivotal trials when and where the outbreak was underway [
 <xref rid="bb0050" ref-type="bibr">10</xref>]. This significantly improved the regulatory and ethics timelines in key areas of presubmission discussions with sponsors and manufacturers, authorization of clinical trials and emergency use of investigational vaccines, and implementation of joint reviews for ethical and regulatory approvals [
 <xref rid="bb0050" ref-type="bibr">10</xref>,
 <xref rid="bb0055" ref-type="bibr">11</xref>]. The leadership of WHO was the cornerstone of this coordinated regulatory response.
</p>
